West Pharmaceutical Services | WST - Sales Revenues



West Pharmaceutical Services reported $766.5M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Align Technology USD 1.01B 30.7M Jun/2025
Avanos Medical USD 175M 7.5M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Cooper Companies USD 1.06B 60.3M Jul/2025
Dentsply International USD 936M 57M Jun/2025
Haemonetics USD 321.39M 9.61M Jun/2025
ICU Medical USD 548.9M 50.59M Jun/2025
Insulet USD 649.1M 80.1M Jun/2025
Integra LifeSciences USD 415.6M 32.9M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Medtronic USD 8.6B 330M Jun/2025
Merit Medical Systems USD 382.5M 27.1M Jun/2025
Neogen USD 225.5M 4.5M May/2025
Quidel USD 614M 79M Jun/2025
Repligen USD 182M 13M Jun/2025
Solventum Corp 2.16B 60M Jun/2025
STAAR Surgical USD 44.3M 1.7M Jun/2025
Terumo JPY 259.97B 3.97B Jun/2025
West Pharmaceutical Services USD 766.5M 68.5M Jun/2025